Type I IFNs at the Interface between Cutaneous Immunity and Epidermal Remodeling

Albanesi, 2009, Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment, J Exp Med, 206, 249, 10.1084/jem.20080129 Bissonnette, 2010, A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis, J Am Acad Dermatol, 62, 427, 10.1016/j.jaad.2009.05.042 Boniface, 2005, IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes, J Immunol, 174, 3695, 10.4049/jimmunol.174.6.3695 Borkowski, 2011, The coordinated response of the physical and antimicrobial peptide barriers of the skin, J Invest Dermatol, 131, 285, 10.1038/jid.2010.360 Capon, 2007, Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis, Hum Genet, 122, 201, 10.1007/s00439-007-0397-0 Cargill, 2007, A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes, Am J Hum Genet, 80, 273, 10.1086/511051 Dorschner, 2001, Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus, J Invest Dermatol, 117, 91, 10.1046/j.1523-1747.2001.01340.x Duhen, 2009, Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells, Nat Immunol, 10, 857, 10.1038/ni.1767 Eyerich, 2009, Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling, J Clin Invest, 119, 3573 Frohm, 1997, The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders, J Biol Chem, 272, 15258, 10.1074/jbc.272.24.15258 Ganguly, 2009, Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8, J Exp Med, 206, 1983, 10.1084/jem.20090480 Gerlini, 2006, Massive recruitment of type I interferon producing plasmacytoid dendritic cells in varicella skin lesions, J Invest Dermatol, 126, 507, 10.1038/sj.jid.5700052 Gilliet, 2008, Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases, Nat Rev Immunol, 8, 594, 10.1038/nri2358 Gregorio, 2010, Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons, J Exp Med, 207, 2921, 10.1084/jem.20101102 Hida, 2000, CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling, Immunity, 13, 643, 10.1016/S1074-7613(00)00064-9 Hollox, 2008, Psoriasis is associated with increased beta-defensin genomic copy number (see comment), Nat Genet, 40, 23, 10.1038/ng.2007.48 Lande, 2011, Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus, Sci Transl Med, 3, 73ra19, 10.1126/scitranslmed.3001180 Lande, 2007, Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide, Nature, 449, 564, 10.1038/nature06116 Lang, 2005, Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease, Nat Med, 11, 138, 10.1038/nm1176 Li, 2011, Cell-intrinsic role for IFN-alpha-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response, Blood, 118, 3879, 10.1182/blood-2011-04-349761 Liang, 2006, Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides, J Exp Med, 203, 2271, 10.1084/jem.20061308 Lin, 2011, Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis, J Immunol, 187, 490, 10.4049/jimmunol.1100123 Lowes, 2007, Pathogenesis and therapy of psoriasis, Nature, 445, 866, 10.1038/nature05663 Luft, 1998, Type I IFNs enhance the terminal differentiation of dendritic cells, J Immunol, 161, 1947, 10.4049/jimmunol.161.4.1947 Marrack, 1999, Type I interferons keep activated T cells alive, J Exp Med, 189, 521, 10.1084/jem.189.3.521 Nestle, 2005, Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production, J Exp Med, 202, 135, 10.1084/jem.20050500 Nestle, 2009, Psoriasis, N Engl J Med, 361, 496, 10.1056/NEJMra0804595 Ong, 2002, Endogenous antimicrobial peptides and skin infections in atopic dermatitis, N Engl J Med, 347, 1151, 10.1056/NEJMoa021481 Peric, 2008, IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes, J Immunol, 181, 8504, 10.4049/jimmunol.181.12.8504 Sanchez, 2008, IFN-regulatory factor 5 gene variants interact with the class I MHC locus in the Swedish psoriasis population, J Invest Dermatol, 128, 1704, 10.1038/sj.jid.5701254 Santini, 2011, Interferon-alpha-conditioned human monocytes combine a Th1-orienting attitude with the induction of autologous Th17 responses: role of IL-23 and IL-12, PloS one, 6, e17364, 10.1371/journal.pone.0017364 Santini, 2000, Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice, J Exp Med, 191, 1777, 10.1084/jem.191.10.1777 Siegal, 1999, The nature of the principal type 1 interferon-producing cells in human blood (see comment), Science, 284, 1835, 10.1126/science.284.5421.1835 Stetson, 2006, Type I interferons in host defense, Immunity, 25, 373, 10.1016/j.immuni.2006.08.007 Theofilopoulos, 2005, Type I interferons (alpha/beta) in immunity and autoimmunity, Annu Rev Immunol, 23, 307, 10.1146/annurev.immunol.23.021704.115843 Tohyama, 2012, IFN-α enhances IL-22 receptor expression in keratinocytes: a possible role in the development of psoriasis, J Invest Dermatol, 132, 1933, 10.1038/jid.2011.468 Tough, 1996, Induction of bystander T cell proliferation by viruses and type I interferon in vivo (see comment), Science, 272, 1947, 10.1126/science.272.5270.1947 Trifari, 2009, Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells, Nat Immunol, 10, 864, 10.1038/ni.1770 Vanbervliet, 2003, The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12, J Exp Med, 198, 823, 10.1084/jem.20020437 Watanabe, 2009, Functional characterization of IL-17F as a selective neutrophil attractant in psoriasis, J Invest Dermatol, 129, 650, 10.1038/jid.2008.294 Wolk, 2009, IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not, J Mol Med (Berl), 87, 523, 10.1007/s00109-009-0457-0 Wolk, 2004, IL-22 increases the innate immunity of tissues, Immunity, 21, 241, 10.1016/j.immuni.2004.07.007 Wollenberg, 2002, Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases, J Invest Dermatol, 119, 1096, 10.1046/j.1523-1747.2002.19515.x Xie, 2000, Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R, J Biol Chem, 275, 31335, 10.1074/jbc.M005304200 Zasloff, 2002, Antimicrobial peptides of multicellular organisms, Nature, 415, 389, 10.1038/415389a Zheng, 2007, Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis, Nature, 445, 648, 10.1038/nature05505